Culturally tailored evidence‐based substance use disorder treatments are efficacious with an American Indian Southwest tribe: an open‐label pilot‐feasibility randomized controlled trial

Venner, K; Serier, Kelsey N.; Sarafin, Ruth E.; Greenfield, Brenna L.; Hirchak, Katherine; Smith, Jane Ellen; Witkiewitz, Katie

doi:10.1111/add.15191

Cited by 35 publications

(52 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Venner et al . [8] addressed this research gap by testing the efficacy of a culturally tailored intervention that combined two evidence‐based SUD treatments, motivational interviewing and the community reinforcement approach (MICRA), among AI participants from one southwest tribe. The authors compared substance use outcomes between participants assigned to the culturally tailored MICRA condition and those assigned to receive treatment as usual (TAU)—standard care through the reservation’s outpatient treatment program.…”

mentioning

confidence: 99%

“…The authors compared substance use outcomes between participants assigned to the culturally tailored MICRA condition and those assigned to receive treatment as usual (TAU)—standard care through the reservation’s outpatient treatment program. Results demonstrated no evidence of between‐group treatment effects, as participants assigned to both groups improved approximately equally with regard to substance use outcomes [8]. Despite these null effects, Venner and colleagues have propelled the field of SUD treatment research in AI communities forward and helped to open the door to greater representation of AIs in randomized controlled trials (RCTs).…”

mentioning

confidence: 99%

“…Venner et al . successfully overcame these barriers by working in close partnership with a tribal community to culturally adapt the evidence‐based treatments selected by tribal leaders [8,14] and by using a community‐based participatory research (CBPR) framework.…”

mentioning

confidence: 99%

“…Moreover, there is evidence of profound resistance to the idea of evidence-based treatments developed by non-Native researchers for non-Native clients being used with tribal members [5,12,13]. Venner et al successfully overcame these barriers by working in close partnership with a tribal community to culturally adapt the evidence-based treatments selected by tribal leaders [8,14] and by using a community-based participatory research (CBPR) framework.…”

mentioning

confidence: 99%

“…A systematic review of barriers and facilitators to participation in clinical trials by Indigenous participants resulted in several recommendations to researchers, including developing close relationships and working in partnership with communities, culturally adapting assessments and intervention materials, employing community members to collect data and implement interventions and honoring and incorporating Indigenous world-views and knowledge systems [9]. Venner and colleagues adhered to these recommendations by engaging in a long-term partnership with the community spanning three successive tribal governments, working closely with their community partners to culturally adapt the evidence-based treatments selected by the tribe, and employing bilingual and culturally embedded staff members at the reservation's SUD treatment center to deliver the intervention [8,14]. They also honored Indigenous knowledge by using an adapted measure of a culturally specific protective factor (Native American Spirituality) as a hypothesized mediator of treatment effects [8,14,16].…”

mentioning

confidence: 99%

See 4 more Smart Citations

Commentary on Venner et al. : Community‐based participatory research opens doors to rigorous addiction treatment research with Indigenous communities

Skewes

2020

Addiction

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Commentary on Venner et al. : Community‐based participatory research opens doors to rigorous addiction treatment research with Indigenous communities

Skewes

2020

Addiction

View full text Add to dashboard Cite

show abstract

Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native Communities: Contributions from a National Collaborative Board

Hirchak

Nadeau

Vásquez

et al. 2022

American J of Comm Psychol

Self Cite

View full text Add to dashboard Cite

American Indian/Alaska Native (AI/AN) communities are disproportionally impacted by the opioid overdose epidemic. There remains a dearth of research evaluating methods for effectively implementing treatments for opioid use disorder (OUD) within these communities. We describe proceedings from a 2‐day Collaborative Board (CB) meeting tasked with developing an implementation intervention for AI/AN clinical programs to improve the delivery of medications to treat OUD (MOUD). The CB was comprised of Elders, cultural leaders, providers, individuals with lived experience with OUD, and researchers from over 25 communities, organizations, and academic institutions. Conversations were audio‐recorded, transcribed, and coded by two academic researchers with interpretation oversight provided by the CB. These proceedings provided a foundation for ongoing CB work and a frame for developing the program‐level implementation intervention using a strength‐based and holistic model of OUD recovery and wellbeing. Topics of discussion posed to the CB included engagement and recovery strategies, integration of extended family traditions, and addressing stigma and building trust with providers and clients. Integration of traditional healing practices, ceremonies, and other cultural practices was recommended. The importance of centering AI/AN culture and involving family were highlighted as priorities for the intervention.

show abstract

A Scoping Review of the Utilization of Opioid Use Treatment, Harm Reduction, and Culturally Tailored Interventions Among Racial/Ethnic Minorities in the United States

Ezell,

Simek,

Shetty

et al. 2024

Int J Ment Health Addiction

View full text Add to dashboard Cite

As part of a multilayered scoping review, we assessed literature on prevention and management interventions for racial/ethnic minorities in the United States (US) who non-medically use prescription opioids and/or who use illicit opioids such as heroin. The review specifically focused on access to and uptake of medications for opioid use disorder (MOUD) and harm reduction resources. We conducted a scoping review of peer-reviewed literature and governmental reports published between January 2000 and August 2024 on patterns of access to, and acceptability and utilization of, overdose prevention and opioid use management resources among racial/ethnic minorities in the US. Searches were conducted on Cochrane, PubMed, Embase, and Google Scholar, with us examining studies on the uptake of MOUD, such as buprenorphine and methadone, syringe services programs (SSPs), safe consumption sites, and harm reduction resources like naloxone (used to reverse overdoses) and fentanyl test strips (used to test for the presence of fentanyl in drug supplies). Additionally, we sought to identify and describe existing interventions for opioid use prevention and management that have expressly incorporated cultural adaptations related to racial/ethnic minorities’ specific needs and preferences in an effort to improve participants' sense of salience and acceptability and thus enhance utilization. We further endeavored to leverage this scoping review towards the development of research and intervention guidelines contoured to improve future scholarship and programming with these populations. The existing evidence suggests that racial/ethnic minorities in the US, specifically Black individuals, have diminished access to and/or utilization of preventive and management resources and amenities such as buprenorphine and naloxone, owing to structural deficits, provider bias, socioeconomic obstacles, geographic barriers, and communal stigma and distrust. Black individuals, relative to White individuals, also appear less likely to report using SSPs to obtain syringes and related resources, but across racial groups, those who used SSPs were more likely to be trained in, possess, and/or use naloxone. Further, there have been very few culturally tailored interventions for harm reduction or MOUD; there were limited data across the reviewed works on Native American/Indigenous or Asian populations; and the broader body of literature lacks methodological rigor. We close by proposing a cultural humility-focused model for better meeting the complex needs of these populations through research and primary and secondary intervention.

show abstract

Culturally tailored evidence‐based substance use disorder treatments are efficacious with an American Indian Southwest tribe: an open‐label pilot‐feasibility randomized controlled trial

Cited by 35 publications

References 72 publications

Commentary on Venner et al. : Community‐based participatory research opens doors to rigorous addiction treatment research with Indigenous communities

Commentary on Venner et al. : Community‐based participatory research opens doors to rigorous addiction treatment research with Indigenous communities

Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native Communities: Contributions from a National Collaborative Board

A Scoping Review of the Utilization of Opioid Use Treatment, Harm Reduction, and Culturally Tailored Interventions Among Racial/Ethnic Minorities in the United States

Contact Info

Product

Resources

About